Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVD
2551
DELISTED
Dover Motorsports
DVD
| $820K | ﹤0.01% |
352,000
+5,600
| +2% | +$12.6K |
|
|
LGF
2552
DELISTED
Lions Gate Entertainment
LGF
| $819K | ﹤0.01% |
+25,298
| New | +$931K |
|
2553
Weibo
WB
$1.99B
| $815K | ﹤0.01% |
+41,800
| New | +$717K |
|
|
ONE
2554
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $813K | ﹤0.01% |
250,811
+89,811
| +56% | +$257K |
|
|
AGU
2555
DELISTED
Agrium
AGU
| $810K | ﹤0.01% |
+9,069
| New | +$858K |
|
2556
Weyco Group
WEYS
$373M
| $808K | ﹤0.01% |
30,200
-9,500
| -24% | -$262K |
|
|
ACFC
2557
DELISTED
Atlantic Coast Financial Corporation
ACFC
| $808K | ﹤0.01% |
137,800
+22,000
| +19% | +$133K |
|
|
NAVB
2558
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $807K | ﹤0.01% |
30,330
+8,380
| +38% | +$291K |
|
2559
Nomura Holdings
NMR
$28.2B
| $805K | ﹤0.01% |
145,000
+50,100
| +53% | +$305K |
|
|
HZN
2560
DELISTED
Horizon Global Corporation
HZN
| $805K | ﹤0.01% |
+77,600
| New | +$707K |
|
|
JCTC
2561
Jewett-Cameron Trading
JCTC
$9.47M
| $803K | ﹤0.01% |
159,800
+2,000
| +1% | +$9.73K |
|
|
TVRD
2562
Tvardi Therapeutics
TVRD
$19M
| $802K | ﹤0.01% |
1,321
-5,668
| -81% | -$3.11M |
|
|
MIXT
2563
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $801K | ﹤0.01% |
189,900
+46,700
| +33% | +$238K |
|
|
SHOE
2564
Shoe Station Group
SHOE
$417M
| $798K | ﹤0.01% |
68,800
-97,600
| -59% | -$1.08M |
|
2565
Malibu Boats
MBUU
$545M
| $794K | ﹤0.01% |
48,500
-28,518
| -37% | -$430K |
|
|
MSB
2566
Mesabi Trust
MSB
$291M
| $794K | ﹤0.01% |
+175,700
| New | +$1.35M |
|
|
ELON
2567
DELISTED
Echelon Corp
ELON
| $792K | ﹤0.01% |
140,427
+24,467
| +21% | +$148K |
|
|
SA
2568
Seabridge Gold
SA
$2.8B
| $789K | ﹤0.01% |
+95,240
| New | +$748K |
|
|
ADVM
2569
DELISTED
Adverum Biotechnologies
ADVM
| $782K | ﹤0.01% |
+8,210
| New | +$721K |
|
2570
Dave & Buster's
PLAY
$376M
| $781K | ﹤0.01% |
18,700
-200,100
| -91% | -$7.83M |
|
2571
Aspen Aerogels
ASPN
$376M
| $778K | ﹤0.01% |
128,100
+32,142
| +33% | +$222K |
|
2572
Ultralife
ULBI
$86.1M
| $778K | ﹤0.01% |
120,500
+60,800
| +102% | +$401K |
|
|
FPI
2573
Farmland Partners
FPI
$410M
| $770K | ﹤0.01% |
70,206
+54,506
| +347% | +$588K |
|
2574
Hecla Mining
HL
$9.51B
| $770K | ﹤0.01% |
407,569
+78,500
| +24% | +$163K |
|
|
CSLT
2575
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $767K | ﹤0.01% |
179,742
+50,842
| +39% | +$218K |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.